6769 MESA RIDGE RD., SAN DIEGO, CA
Reports Second Quarter 2026 Financial Results and Recent Business Highlights
News, Underwriting Agreement, Securities Holder Rights or Indentures, Legal Opinion
Earnings Release
Bylaws Amendment Approved; Role of Chairman Clarified at Inovio Pharmaceuticals
Reports First Quarter 2026 Financial Results and Recent Business Highlights
Announces Pricing of $17.5 Million Public Offering
Other Events
Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership